Although other studies reported GILT expression in human melanoma tumors by immunohistochemistry [34], our study suggests that infiltrating cells, but not metastatic melanoma, express GILT, and that GILT-expressing melanomas are a better target for CD4+ T cells. The gene discussed is IFI30; the disease is metastatic melanoma.